Molecular Imaging of HER2 Expression in Breast Cancer Using [123I] I-(HE)3-G3
Clinical trial NCT05923177 · COMPLETED
Trial details
- NCT number
- NCT05923177
- Sponsor
- Tomsk National Research Medical Center of the Russian Academy of Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2024-09-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.